Antitumor Effect of Somatostatin Analogs in Neuroendocrine Tumors

被引：6
|
作者：
Chua, Yu Jo [1 ]
Michael, Michael [2 ]
Zalcberg, John R. [2 ]
Hicks, Rod J. [3 ]
Goldstein, David [4 ]
Liauw, Winston [5 ]
Price, Timothy [6 ]
机构：
[1] Canberra Hosp, Med Oncol Unit, Canberra, ACT, Australia
[2] Peter MacCallum Canc Ctr, Div Haematol & Med Oncol, Melbourne, Australia
[3] Peter MacCallum Canc Ctr, Ctr Mol Imaging, Melbourne, Australia
[4] Prince Wales Hosp, Dept Med Oncol, Randwick, NSW 2031, Australia
[5] St George Hosp, Canc Care Ctr, Kogarah, NSW, Australia
[6] Queen Elizabeth Hosp, Dept Oncol, Woodville, SA 5011, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 03期
关键词：
D O I：
10.1200/JCO.2009.26.0612
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E41 / E42
页数：2
相关论文
共 50 条
  • [21] Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
    J. E. Machado-Alba
    M. E. Machado-Duque
    A. Gaviria-Mendoza
    I. N. Arsof-Saab
    C. A. Castellanos-Moreno
    L. Botero
    L. Triana
    Journal of Endocrinological Investigation, 2023, 46 : 27 - 35
  • [22] The Expanding Role of Somatostatin Analogs in Gastroenteropancreatic and Lung Neuroendocrine Tumors
    Mauro Cives
    Jonathan Strosberg
    Drugs, 2015, 75 : 847 - 858
  • [23] Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors
    Ozhan, M.
    Kabasakal, L.
    Mut, S. Senyuz
    Nisli, S.
    Gunes, B.
    Uslu, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S437 - S437
  • [24] Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspects
    Mazziotti, Gherardo
    Mosca, Alessandra
    Frara, Stefano
    Vitale, Giovanni
    Giustina, Andrea
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (16) : 1679 - 1689
  • [25] Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors
    Allaw, Mohammed B.
    Switchenko, Jeffrey M.
    Khalil, Lana
    Wu, Christina
    Alese, Olatunji B.
    Akce, Mehmet
    Draper, Amber
    Jones, Aaron T.
    El-Rayes, Bassel
    Shaib, Walid
    ONCOLOGY, 2022, : 131 - 139
  • [26] Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
    Machado-Alba, J. E.
    Machado-Duque, M. E.
    Gaviria-Mendoza, A.
    Arsof-Saab, I. N.
    Castellanos-Moreno, C. A.
    Botero, L.
    Triana, L.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2023, 46 (01) : 27 - 35
  • [27] Antiproliferative Effect of Above-Label Doses of Somatostatin Analogs for the Management of Gastroenteropancreatic Neuroendocrine Tumors
    Diamantopoulos, Leonidas Nikolaos
    Laskaratos, Faidon-Marios
    Kalligeros, Markos
    Shah, Ruchir
    Navalkissoor, Shaunak
    Gnanasegaran, Gopinath
    Banks, Jamie
    Smith, Jack
    Jacobs, Benjamin
    Galanopoulos, Michail
    Mandair, Dalvinder
    Caplin, Martyn
    Toumpanakis, Christos
    NEUROENDOCRINOLOGY, 2021, 111 (07) : 650 - 659
  • [28] Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors
    Clarke, Callisia N.
    Cockrum, Paul
    Beveridge, Thomas J. R.
    Jerry, Michelle
    McMorrow, Donna
    Anh Thu Tran
    Phan, Alexandria T.
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2023, 10 (02): : 121 - 131
  • [29] The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives
    Lauricella, Eleonora
    Vilisova, Sofija
    Chaoul, Nada
    Giglio, Andrea
    D'Angelo, Gabriella
    Porta, Camillo
    Cives, Mauro
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2025, 25 (02) : 245 - 258
  • [30] Gastrointestinal side effects of somatostatin analogs in neuroendocrine tumors: a focused review
    Marasco, Matteo
    Dell'Unto, Elisabetta
    Laviano, Alessandro
    Campana, Davide
    Panzuto, Francesco
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (09) : 1737 - 1744
12345